Please use this identifier to cite or link to this item:
|Title:||Plant production of a tumour-targeting human IgG. Considerations on expression strategies, glycosylation profile and in planta proteolysis||Authors:||Lombardi, Raffaele||Keywords:||Molecular farming;Plant-derived mAb;Transient expression;BIO/15||Issue Date:||11-Apr-2012||Publisher:||Università degli studi della Tuscia - Viterbo||Series/Report no.:||Tesi di dottorato di ricerca. 24. ciclo||Abstract:||
Compared to other expression platforms, plants present several advantages for the expression of
recombinant antibodies such as the ability to assemble multimers, the possibility to achieve posttranslational
modifications similar to those found in mammalian cells, low management costs and
ease of scalability. Despite these advantages, some drawbacks need to be addressed.
One of the limits of the plant expression systems, is represented by downstream purification steps,
in which many factors, such as low antibody concentration, extraction methodologies and
purification strategy, could influence the effectiveness of the purification. Another important issue
to be addressed in the use of plants for antibody expression, is represented by plant glycosylation.
The considerable differences between the sugar moieties harbored by proteins expressed in plants
and mammals, represents a major drawback in the application of the plant-derived
immunoglobulins in human therapy since the possible immunogenicity of these sugar moieties. An
additional drawback of recombinant antibodies obtained from plants is represented by the final
recovery yield, that can be, in some cases, reduced by the unintended proteolytic process taking
place in the plant cell machinery. Particularly, in the case of antibody expression, as reported in
many studies, degradation could produce a protein reduction of about 90 % of the final purified
In this work, we described the expression of the human recombinant antitumoral antibody H10 in
Nicotiana benthamiana using a transient expression system based on vacuum agroinfiltration,
focusing our research efforts on the above mentioned issues: extraction and purification strategies,
glycosylation profile and proteolysis.
The first part of the work emphasized that the application of different extraction methodologies was
able to significantly affect the integrity and yield of the IgG H10 antibody purified from
agroinfiltrated N. benthamiana leaves. Based on the data collected, we optimized a pilot-scale
purification method, using a two-step purification protocol from 250 g of fresh agroinfiltrated
leaves obtaining an average yield of 40 mg per Kg fresh weight of intact IgG with 99.4 % purity,
with endotoxin levels < 1 EU/ml, free of phenolic, alkaloid compounds. In the second part, the
glycosylation pattern of plant produced H10 was modulated using three different strategies in order
to study the effect of the different glycosylation profiles on antibody quality and plant expression
yield. Finally, the proteolysis of the plant-derived IgG H10 was studied in order to analyze in planta
antibody degradation profile and to identify specific cleavage sites of the immunoglobulin.
Furthermore, an in silico analysis permitted the identification of proteases responsible of the
Data herein represent valid a contribution in the field of plant-made antibodies, and intend to
provide new information in the molecular pharming area. Our research efforts aimed to confirm the
possibility to over-express immunoglobulins with a “human like” glycosylation profile in N.
benthamiana plants, reducing the unintended plant proteolysis to increase the final yield of intact
Dottorato di ricerca in Biotecnologie vegetali
|Appears in Collections:||Archivio delle tesi di dottorato di ricerca|
Show full item record
checked on Oct 31, 2020
checked on Oct 31, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.